202 related articles for article (PubMed ID: 21084834)
1. Inhibition of Cot1/Tlp2 oncogene in AML cells reduces ERK5 activation and up-regulates p27Kip1 concomitant with enhancement of differentiation and cell cycle arrest induced by silibinin and 1,25-dihydroxyvitamin D(3).
Wang X; Gocek E; Novik V; Harrison JS; Danilenko M; Studzinski GP
Cell Cycle; 2010 Nov; 9(22):4542-51. PubMed ID: 21084834
[TBL] [Abstract][Full Text] [Related]
2. Oncoprotein Cot1 represses kinase suppressors of Ras1/2 and 1,25-dihydroxyvitamin D3-induced differentiation of human acute myeloid leukemia cells.
Wang X; Studzinski GP
J Cell Physiol; 2011 May; 226(5):1232-40. PubMed ID: 20945381
[TBL] [Abstract][Full Text] [Related]
3. Expression of MAP3 kinase COT1 is up-regulated by 1,25-dihydroxyvitamin D3 in parallel with activated c-jun during differentiation of human myeloid leukemia cells.
Wang X; Studzinski GP
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):395-8. PubMed ID: 20227498
[TBL] [Abstract][Full Text] [Related]
4. A combination of 1α,25-dihydroxyvitamin D3, a plant-derived antioxidant and an inhibitor of the Cot1/Tlp2 oncogene as molecularly targeted weapons in the hematologist's battle against acute myeloid leukemias.
Hughes PJ; Brown G
Cell Cycle; 2010 Dec; 9(23):4612-3. PubMed ID: 21260950
[No Abstract] [Full Text] [Related]
5. 1,25-Dihydroxyvitamin D3 induces monocytic differentiation of human myeloid leukemia cells by regulating C/EBPβ expression through MEF2C.
Zheng R; Wang X; Studzinski GP
J Steroid Biochem Mol Biol; 2015 Apr; 148():132-7. PubMed ID: 25448741
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor p53 status does not determine the differentiation-associated G₁ cell cycle arrest induced in leukemia cells by 1,25-dihydroxyvitamin D₃ and antioxidants.
Thompson T; Danilenko M; Vassilev L; Studzinski GP
Cancer Biol Ther; 2010 Aug; 10(4):344-50. PubMed ID: 20543580
[TBL] [Abstract][Full Text] [Related]
7. ERK 5/MAPK pathway has a major role in 1α,25-(OH)2 vitamin D3-induced terminal differentiation of myeloid leukemia cells.
Wang X; Pesakhov S; Weng A; Kafka M; Gocek E; Nguyen M; Harrison JS; Danilenko M; Studzinski GP
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():223-7. PubMed ID: 24514755
[TBL] [Abstract][Full Text] [Related]
8. Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistance.
Chen-Deutsch X; Studzinski GP
Cell Cycle; 2012 Apr; 11(7):1364-73. PubMed ID: 22421156
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3.
Wang X; Gocek E; Liu CG; Studzinski GP
Cell Cycle; 2009 Mar; 8(5):736-41. PubMed ID: 19221487
[TBL] [Abstract][Full Text] [Related]
10. Silibinin can induce differentiation as well as enhance vitamin D3-induced differentiation of human AML cells ex vivo and regulates the levels of differentiation-related transcription factors.
Zhang J; Harrison JS; Uskokovic M; Danilenko M; Studzinski GP
Hematol Oncol; 2010 Sep; 28(3):124-32. PubMed ID: 19866452
[TBL] [Abstract][Full Text] [Related]
11. 1,25-dihydroxyvitamin D3 enhances the apoptotic activity of MDM2 antagonist nutlin-3a in acute myeloid leukemia cells expressing wild-type p53.
Thompson T; Andreeff M; Studzinski GP; Vassilev LT
Mol Cancer Ther; 2010 May; 9(5):1158-68. PubMed ID: 20406950
[TBL] [Abstract][Full Text] [Related]
12. Cell-Type-Specific Effects of Silibinin on Vitamin D-Induced Differentiation of Acute Myeloid Leukemia Cells Are Associated with Differential Modulation of RXRα Levels.
Wassermann R; Novik V; Danilenko M
Leuk Res Treatment; 2012; 2012():401784. PubMed ID: 23259067
[TBL] [Abstract][Full Text] [Related]
13. p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells.
Roy S; Kaur M; Agarwal C; Tecklenburg M; Sclafani RA; Agarwal R
Mol Cancer Ther; 2007 Oct; 6(10):2696-707. PubMed ID: 17938263
[TBL] [Abstract][Full Text] [Related]
14. Icariside II induces cell cycle arrest and differentiation via TLR8/MyD88/p38 pathway in acute myeloid leukemia cells.
Yang J; Lan J; Du H; Zhang X; Li A; Zhang X; Liu Y; Zhang J; Zhang C; Ding Y; Zhang T
Eur J Pharmacol; 2019 Mar; 846():12-22. PubMed ID: 30579933
[TBL] [Abstract][Full Text] [Related]
15. ERK5 pathway regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells.
Wang X; Pesakhov S; Harrison JS; Danilenko M; Studzinski GP
J Cell Physiol; 2014 Jul; 229(7):856-67. PubMed ID: 24264602
[TBL] [Abstract][Full Text] [Related]
16. Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1alpha,25-dihydroxyvitamin D3 in leukemia cells but does not promote elevation of basal levels of intracellular calcium.
Danilenko M; Wang Q; Wang X; Levy J; Sharoni Y; Studzinski GP
Cancer Res; 2003 Mar; 63(6):1325-32. PubMed ID: 12649194
[TBL] [Abstract][Full Text] [Related]
17. The cancer preventive flavonoid silibinin causes hypophosphorylation of Rb/p107 and Rb2/p130 via modulation of cell cycle regulators in human prostate carcinoma DU145 cells.
Tyagi A; Agarwal C; Agarwal R
Cell Cycle; 2002; 1(2):137-42. PubMed ID: 12429923
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
Gysin S; Lee SH; Dean NM; McMahon M
Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
[TBL] [Abstract][Full Text] [Related]
19. Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3.
Bali P; George P; Cohen P; Tao J; Guo F; Sigua C; Vishvanath A; Scuto A; Annavarapu S; Fiskus W; Moscinski L; Atadja P; Bhalla K
Clin Cancer Res; 2004 Aug; 10(15):4991-7. PubMed ID: 15297399
[TBL] [Abstract][Full Text] [Related]
20. Optimal AraC-Cytotoxicity to AML Cells Requires ERK5 Activity.
Zheng R; Studzinski GP
J Cell Biochem; 2017 Jun; 118(6):1583-1589. PubMed ID: 27922189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
